Sucampo Announces Webcast of Its Presentation at the 14th Annual Needham Healthcare Conference
April 07 2015 - 6:45AM
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global
biopharmaceutical company, today announced that it will webcast its
corporate presentation at the 14th Annual Needham Healthcare
Conference taking place April 14, 2015 at 1:40 PM ET.
Investors interested in arranging a meeting with the Company's
management during this conference should contact the conference
coordinator.
The presentation will be webcast live and may be accessed from
the Event Calendar page of Sucampo's website at
http://www.sucampo.com/investors/events-presentations/.
Presentation slides will be available via the webcast links. A
replay of the webcast will also be available on the Company's
website for several days after the live event. To ensure a timely
connection, it is recommended that users register at least 15
minutes prior to the scheduled webcast.
About Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. is focused on the development and
commercialization of medicines that meet major unmet medical needs
of patients worldwide. Sucampo has one marketed product – AMITIZA®
– and a pipeline of drug candidates in clinical development. A
global company, Sucampo is headquartered in Bethesda, Maryland, and
has operations in Japan, Switzerland and the United Kingdom. For
more information, please visit www.sucampo.com.
The Sucampo logo and the tagline, The Science of Innovation, are
registered trademarks of Sucampo AG. AMITIZA is a registered
trademark of Sucampo AG.
Follow us on Twitter (@Sucampo_Pharma). Follow us on LinkedIn
(Sucampo Pharmaceuticals).
Twitter LinkedIn
Sucampo Forward-Looking Statement
This press release contains "forward-looking statements" as that
term is defined in the Private Securities Litigation Reform Act of
1995. These statements are based on management's current
expectations and involve risks and uncertainties, which may cause
results to differ materially from those set forth in the
statements. The forward-looking statements may include statements
regarding product development, product potential, future financial
and operating results, and other statements that are not historical
facts. The following factors, among others, could cause actual
results to differ from those set forth in the forward-looking
statements: the impact of pharmaceutical industry regulation and
health care legislation; the ability of Sucampo to develop and
commercialize existing and pipeline products; Sucampo's ability to
accurately predict future market conditions; dependence on the
effectiveness of Sucampo's patents and other protections for
innovative products; the risk of new and changing regulation and
health policies in the U.S. and internationally; the effects of
competitive products on Sucampo's products; and the exposure to
litigation and/or regulatory actions.
No forward-looking statement can be guaranteed and actual
results may differ materially from those projected. Sucampo
undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events,
or otherwise. Forward-looking statements in this presentation
should be evaluated together with the many uncertainties that
affect Sucampo's business, particularly those mentioned in the risk
factors and cautionary statements in Sucampo's most recent Form
10-K as filed with the Securities and Exchange Commission on March
9, 2015.
CONTACT: Company Contact:
Silvia Taylor
SVP, Investor Relations and
Corporate Communications
1-240-223-3718
staylor@sucampo.com
Sucampo Pharmaceuticals, Inc. (delisted) (NASDAQ:SCMP)
Historical Stock Chart
From Apr 2024 to May 2024
Sucampo Pharmaceuticals, Inc. (delisted) (NASDAQ:SCMP)
Historical Stock Chart
From May 2023 to May 2024